<html dir="ltr">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=Windows-1252">
<style id="owaParaStyle">P {
MARGIN-BOTTOM: 0px; MARGIN-TOP: 0px
}
</style>
</head>
<body fPStyle="1" ocsi="0">
<div style="direction: ltr;font-family: Tahoma;color: #000000;font-size: 10pt;">
<div>
<p>Executives and managers of pharmaceutical manufacturer Insys were accused, in December, of bribing doctors to do off label prescribing of a powerful opioid sold under the trade name, "Subsys". Now, Sen. McCaskill, who leads a Congressional investigation
into drug makers’ roles in the national opioid addiction epidemic, has released evidence that they used fraudulent prior authorization practices to get insurers to pay, even after executives were warned by a consultant of the lack of oversight. </p>
<blockquote style="MARGIN-RIGHT: 0px" dir="ltr">
<p>"Federal prosecutors alleged that Babich and the other former Insys executives “approved and fostered” fraudulent prior authorization practices..."</p>
<p>Insys “lacked even basic measures to prevent its employees from manipulating the prior authorization process and received clear notice of these deficiencies,”<br>
“In the case of Subsys patient Sarah Fuller, an audio recording reveals that an Insys employee repeatedly misled representatives of Envision Pharmaceutical Services to obtain approval for her prescription,” the McCaskill report concluded. “The result, in the
case of Ms. Fuller, was death due to allegedly improper and excessive Subsys use.”
</p>
</blockquote>
<p>Insys is also being sued by Anthem, an insurer who says that 54% of claims, totaling $19 million, that they paid to Insys for Sybsys prescriptions were falsified.
</p>
<p> </p>
<p><a href="https://www.statnews.com/pharmalot/2017/09/06/insys-warnings-subsys-mccaskill/?utm_source=STAT+Newsletters&utm_campaign=3e2a46f06c-MR&utm_medium=email&utm_term=0_8cab1d7961-3e2a46f06c-149620549">https://www.statnews.com/pharmalot/2017/09/06/insys-warnings-subsys-mccaskill/?utm_source=STAT+Newsletters&utm_campaign=3e2a46f06c-MR&utm_medium=email&utm_term=0_8cab1d7961-3e2a46f06c-149620549</a></p>
<p> </p>
<p>also:</p>
<p> </p>
<p><a href="http://www.reuters.com/article/us-insys-opioids/senator-reveals-results-of-opioid-inquiry-into-insys-idUSKCN1BH34O?feedType=RSS&virtualBrandChannel=11563">http://www.reuters.com/article/us-insys-opioids/senator-reveals-results-of-opioid-inquiry-into-insys-idUSKCN1BH34O?feedType=RSS&virtualBrandChannel=11563</a></p>
<p> </p>
<p> </p>
<div style="FONT-SIZE: 13px; FONT-FAMILY: Tahoma">
<div style="FONT-SIZE: 13px; FONT-FAMILY: Tahoma">
<div style="FONT-SIZE: 13px; FONT-FAMILY: Tahoma"><font size="+0"><span lang="en-US">
<div><font size="2">Ed Gottlieb<br>
Chair, Coalition for Safe Medication Disposal<br>
Board Member, New York Product Stewardship Council<br>
</font></div>
<font size="2"></font>
<div><font size="2">Industrial Pretreatment Coordinator</font></div>
<font size="2"></font>
<div><font size="2">Ithaca Area Wastewater Treatment Facility</font><br>
<font size="2">525 3</font><sup>rd</sup><font size="2"> Street</font></div>
<font size="2"></font>
<div><font size="2">Ithaca, NY 14850</font></div>
<font size="2"></font>
<div><font size="2">(607) 273-8381</font></div>
<font size="2"></font>
<div><font size="2">fax: (607) 273-8433</font></div>
</span></font></div>
</div>
</div>
</div>
</div>
</body>
</html>